Can a daily drop soothe your cough? new study investigates

NCT ID NCT07694284

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study tests whether a dietary supplement called Super Lungs Liquid Drops can improve respiratory comfort and soothe airway irritation in generally healthy adults aged 18 to 65 who have bothersome coughing or throat symptoms. All 35 participants take 2 mL of the drops daily for 12 weeks and report changes in breathing comfort and well-being. The trial is fully virtual and open-label, meaning everyone knows they are receiving the supplement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Super Lungs Liquid Drops (dietary supplement)
What this could lead to
If it works, this supplement could offer a natural option for easing cough and throat discomfort without medication.
What could go wrong
This is a small, early-stage trial with no placebo group, so results may be influenced by expectation. The supplement may not provide noticeable relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 35 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18-65 years. * Over the past two months, has experienced bothersome coughing on a weekly basis. * Anyone who has experienced issues with at least two of the following over the past four weeks: chest tightness or congestion; persistent throat irritation or itchiness; excess mucus or phlegm buildup. * Generally healthy, without any uncontrolled chronic disease. * Willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial. * Resides in the United States. * Has access to the internet and a device (smartphone, tablet, or computer) capable of completing online questionnaires. * Willing to follow the study protocol and complete all required assessments. Exclusion Criteria: * Anyone with a known allergy or sensitivity to any of the study product ingredients. * Anyone with a known allergy to plants in the Asteraceae/Compositae family. * Women who are pregnant, breastfeeding, or planning to become pregnant during the study period. * Anyone currently taking immunosuppressant medications (e.g., cyclosporine, methotrexate, biologics such as adalimumab or infliximab). * Anyone with a diagnosed autoimmune disorder (e.g., lupus, rheumatoid arthritis, multiple sclerosis). * Anyone with uncontrolled hypertension or currently taking antihypertensive medications, diuretics, or corticosteroids. * Anyone currently taking anticoagulant or antiplatelet medications (e.g., warfarin, heparin, clopidogrel). * Anyone with a chronic health condition that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, a history of substance abuse, or planned surgery during the study period. * Anyone with a history of alcohol use disorder or currently in alcohol recovery. * Anyone currently participating in another research study or who plans to participate in another study during the study period. (

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coughing are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cough

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Citruslabs

    Las Vegas, Nevada, 89118, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.